ARCHIVES

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001

In Brief: Lame Ducks continue On NCAB; Calabresi Elected To IOM; Ravikumar Moves To Yale

September 28, 1990